PUBLIC COMPANY
save$HINDVyome Holdings, Inc
$HINDSan Clemente, CA, USupdated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- 'Incorrect and misleading' data prompted decision to pull Tavneos in EuropeEuropean regulators on Thursday explained last week's decision to pull Amgen's rare disease drug Tavneos from the market there, detailing their skepticism about the data. In new documents posted Th…endpoints · 3d ago
- What’s behind the proposed pullback on remote patient monitoringCompanies that help doctors keep tabs on their patients at home are freaking out after Medicare's proposal last week to gut remote patient monitoring, or RPM. The plan is a total about-face from th…endpoints · 25d ago
- House lawmakers back trade probe of China biotech, sequencingAt least 10 House lawmakers are backing a US trade panel’s probe of China’s biotech sector and related pricing practices, encouraging future executive action. In a letter sent to Secretary of the U…endpoints · 28d ago
- Former Akero team announces new I&I company, Avere, with China drugEverything around China biotech really does seem to be speeding up. On Tuesday, the former executive team behind Akero Therapeutics unveiled a new company, a pipeline drug from China and a reverse…endpoints · 1mo ago
- HHS lays groundwork for new FDA rule on releasing CRLsThe Trump administration is pushing the FDA to cement the details behind its proactive public release of rejection letters sent to pharma companies. The push comes as an HHS spokesperson confirmed…endpoints · 1mo ago
- Eli Lilly's TuneLab hits 100 members, adding Chai's AI modelsThe leader behind TuneLab, Eli Lilly's first-of-its-kind AI initiative, had no idea what to expect when it launched. Lilly was trying something new by effectively offering biotechs free access to s…endpoints · 2mo ago
- Post-Hoc Live: How much is everyone in biopharma getting paid?The one law of CEO pay packages: They keep getting bigger. Yesterday, we published the first installment of Endpoints News’ annual biopharma compensation project. Following our analysis of the indu…endpoints · 2mo ago
- Behind Galapagos’ transformation into Lakefront BiotherapeuticsCHICAGO — From a 22nd-floor office overlooking the Chicago Riverwalk, in the heart of the Midwest hub’s white-collar downtown district, Lakefront Biotherapeutics’ executives hope to stage the compa…endpoints · 3mo ago
- Biotech’s new company model; The super poop behind a startup launch; and moreWelcome back to another edition of Endpoints Weekly! Earnings season is in full swing, but we had plenty of original reporting and exclusives you won’t find anywhere else this week. Chief among the…endpoints · 3mo ago
- Microbiome startup raises $48M for immunotherapy and malnutrition treatmentsScientists trying to understand why cancer immunotherapy works so well for some patients and not others have found a potential answer in one cancer survivor's poop. A biotech startup has studied th…endpoints · 3mo ago
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that